期刊
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
卷 31, 期 12, 页码 2091-2096出版社
WILEY
DOI: 10.1111/jdv.14389
关键词
-
类别
资金
- Swiss National Foundation [310030_140616]
- Swiss National Science Foundation (SNF) [310030_140616] Funding Source: Swiss National Science Foundation (SNF)
BackgroundHidradenitis suppurativa (HS) is a recalcitrant chronic skin disease with poorly understood immunopathogenic mechanisms. Previous studies reported that the interleukin-36 (IL-36) cytokines [IL-36, IL-36, IL-36 and IL-36 receptor antagonists (IL-36RA)] are important players in the pathogenesis of psoriasis (PS). ObjectiveWe aim to determine whether the IL-36 cytokines are upregulated in patients with HS. For this purpose, we analysed local expression and systemic levels of the IL-36 cytokines in patients with HS and compared the results to healthy donors and patients with PS. MethodsSkin biopsies from healthy donors and HS and PS patients were analysed for expression of the IL-36 cytokines by immunohistochemistry and semiquantitative real-time PCR. The enzyme-linked immunosorbent assay (ELISA) was used to measure systemic levels of the IL-36 cytokines in the serum of the three donor groups. ResultsThe agonists IL-36, IL-36 and IL-36 were found to be upregulated in HS both systemically and lesionally, while the IL-36RA was not differently regulated in comparison to healthy donors. ConclusionOur findings suggest that the agonistic IL-36 isoforms are upregulated in HS. The relevance of the enhanced production of IL-36 cytokines in HS pathogenesis remains to be determined.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据